EP. 2: CBD, THC’s Mild-Mannered Kin, is a Risk Worth Watching

Cannabidiol (CBD), a chemical compound from the Cannabid sativa plant, may be less potent than its stony cannabis cousin THC, however CBD might be the far riskier relative. Nearly a dozen major CBD-related class action lawsuits, as well as a handful of legal and regulatory actions against some CBD companies, are pending. All of this bears watching by those in the sector who manage and deal in risk.

Other videos you might like:

• EP. 25: Some Insurance Regulators Are Urging Carriers to Insure Cannabis
• EP. 18: Insuring Public Cannabis Companies is the Business to be in
• ICS20 Soundbite: Legal Space Moving at Light Speed
• EP. 13: How Election Results Could Greenlight Federal Cannabis Legalization